Green light for GENEGUT

A new treatment for Crohn’s Disease?

The European Commission recently selected the GENEGUT research and innovation action for funding as one out of 84 submitted project proposals. Led by the School of Pharmacy and APC Microbiome Ireland SFI Research Centre at University College Cork (UCC), the project aims to transfer the revolutionary RNA technology to treat ileal Crohn’s Disease – a potential game-changer.

The project brings together 9 Partners from 8 different European countries to tackle this ambitious task. 

The Research and Innovation action is set to start on 1st October 2022 with the long-term vision to develop a first in class gene therapy to improve the quality of life for millions of Crohn’s disease sufferers.